2026 Global: Anesthesia Laryngeal Masks Market -Competitive Review (2032) report
Description
The 2026 Global: Anesthesia Laryngeal Masks Market -Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for anesthesia laryngeal masks market by geography and historical trend. The scope of the report extends to sizing of the anesthesia laryngeal masks market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
The anesthesia laryngeal masks market is dominated by a group of global medical device manufacturers whose products span single-use and reusable supraglottic airway devices; leading companies commonly cited are Teleflex (including the LMA™ Brand), Ambu A/S, Medtronic, Intersurgical, BD (Becton, Dickinson and Company), Medline, Mercury Medical, Smiths Medical, Thermo Fisher Scientific (and affiliated brands), and Verathon, each contributing through extensive product portfolios, distribution networks, and clinical evidence supporting laryngeal mask adoption. Teleflex is frequently identified as a market leader following strategic brand acquisitions and a broad LMA family used across hospitals and ambulatory surgical centers, and its position is reinforced by its global sales and hospital contracting presence. Ambu A/S competes strongly with disposable and advanced second‑generation devices such as AuraGain and AuraOnce and pursues product upgrades and cross‑sell opportunities with video laryngoscopy to grow share in operating rooms and ASCs. Medtronic, a large diversified medical technology company, expanded its anesthesia airway footprint through acquisitions and regional investment, leveraging scale and clinical reach to support adoption of its supraglottic airway solutions.
Intersurgical, historically known for single‑use devices including gel‑based i‑gel designs and pediatric offerings, is a key innovation and volume player in many regional markets and has been the subject of consolidation activity that further alters competitive dynamics. BD and Medline—large providers of hospital consumables and disposables—supply laryngeal masks as part of broader anesthesia and perioperative portfolios, enabling bundled purchasing and deep penetration into hospital supply chains. Mercury Medical and Smiths Medical (and related specialty airway brands) serve niche and regional channels with a mix of reusable and disposable LMAs that meet differing procurement and infection‑control priorities. Thermo Fisher Scientific and Verathon appear among lists of prominent competitors and adjacent‑technology companies, bringing complementary products, laboratory and clinical support capabilities, and, in some cases, specialized airway or visualization adjuncts that integrate with laryngeal mask usage.
Market behavior among these ten firms is shaped by trends favoring disposable devices for infection control, second‑generation masks that improve seal and aspiration protection, pediatric and neonate sizing, and sustainability and digital traceability initiatives that large suppliers pilot with health systems. Competitive strategies include product innovation (improved materials, gel cuffs, integrated channels), mergers and acquisitions to consolidate brands and distribution, and regional manufacturing/registration to access fast‑growing Asia‑Pacific and emerging markets where surgical volumes and healthcare spending are rising. Hospitals and ambulatory surgical centers remain primary end users, and procurement decisions typically weigh device performance data, cost per case, regulatory compliance, and the ability of suppliers to provide training and long‑term supply agreements—factors that advantage established global suppliers among the ten major companies cited across industry reports.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for anesthesia laryngeal masks market by geography and historical trend. The scope of the report extends to sizing of the anesthesia laryngeal masks market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
The anesthesia laryngeal masks market is dominated by a group of global medical device manufacturers whose products span single-use and reusable supraglottic airway devices; leading companies commonly cited are Teleflex (including the LMA™ Brand), Ambu A/S, Medtronic, Intersurgical, BD (Becton, Dickinson and Company), Medline, Mercury Medical, Smiths Medical, Thermo Fisher Scientific (and affiliated brands), and Verathon, each contributing through extensive product portfolios, distribution networks, and clinical evidence supporting laryngeal mask adoption. Teleflex is frequently identified as a market leader following strategic brand acquisitions and a broad LMA family used across hospitals and ambulatory surgical centers, and its position is reinforced by its global sales and hospital contracting presence. Ambu A/S competes strongly with disposable and advanced second‑generation devices such as AuraGain and AuraOnce and pursues product upgrades and cross‑sell opportunities with video laryngoscopy to grow share in operating rooms and ASCs. Medtronic, a large diversified medical technology company, expanded its anesthesia airway footprint through acquisitions and regional investment, leveraging scale and clinical reach to support adoption of its supraglottic airway solutions.
Intersurgical, historically known for single‑use devices including gel‑based i‑gel designs and pediatric offerings, is a key innovation and volume player in many regional markets and has been the subject of consolidation activity that further alters competitive dynamics. BD and Medline—large providers of hospital consumables and disposables—supply laryngeal masks as part of broader anesthesia and perioperative portfolios, enabling bundled purchasing and deep penetration into hospital supply chains. Mercury Medical and Smiths Medical (and related specialty airway brands) serve niche and regional channels with a mix of reusable and disposable LMAs that meet differing procurement and infection‑control priorities. Thermo Fisher Scientific and Verathon appear among lists of prominent competitors and adjacent‑technology companies, bringing complementary products, laboratory and clinical support capabilities, and, in some cases, specialized airway or visualization adjuncts that integrate with laryngeal mask usage.
Market behavior among these ten firms is shaped by trends favoring disposable devices for infection control, second‑generation masks that improve seal and aspiration protection, pediatric and neonate sizing, and sustainability and digital traceability initiatives that large suppliers pilot with health systems. Competitive strategies include product innovation (improved materials, gel cuffs, integrated channels), mergers and acquisitions to consolidate brands and distribution, and regional manufacturing/registration to access fast‑growing Asia‑Pacific and emerging markets where surgical volumes and healthcare spending are rising. Hospitals and ambulatory surgical centers remain primary end users, and procurement decisions typically weigh device performance data, cost per case, regulatory compliance, and the ability of suppliers to provide training and long‑term supply agreements—factors that advantage established global suppliers among the ten major companies cited across industry reports.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.